DELFIA® assays bring convenience in monoclonal anitbody development

  • Published 2001

Abstract

By using sensitive DELFIA immunoassays for screening one can be confident that all the antibody-producing hybrids can be found. The ease, sensitivity and versatility of this assay makes it possible to test the hybridoma supernatants against different antigens in parallel. The assays can be optimized to fulfil specific needs for convenience; lanthanide-labelled compounds and buffers are commercially available or specific reagents can be prepared to meet users’ individual needs.

4 Figures and Tables

Cite this paper

@inproceedings{2001DELFIAAB, title={DELFIA® assays bring convenience in monoclonal anitbody development}, author={}, year={2001} }